# Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

> **NCT02097147** · PHASE1 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 202 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Vilazodone 20 mg
- **DRUG:** Vilazodone 40 mg
- **DRUG:** Paroxetine 20 mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02097147
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-09
- **Final completion:** 2014-11
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2015-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097147, "Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02097147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*